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Abstract
Background: Antigens for Hantavirus serological tests have been produced using DNA recombinant technology
for more than twenty years. Several different strategies have been used for that purpose. All of them avoid the
risks and difficulties involved in multiplying Hantavirus in the laboratory. In Brazil, the Araraquara virus is one of the
main causes of Hantavirus Cardio-Pulmonary Syndrome (HCPS).
Methods: In this investigation, we report the expression of the N protein of the Araraquara Hantavirus in a
Baculovirus Expression System, the use of this protein in IgM and IgG ELISA and comparison with the same
antigen generated in E. coli.
Results: The protein obtained, and purified in a nickel column, was effectively recognized by antibodies from
confirmed HCPS patients. Comparison of the baculovirus generated antigen with the N protein produced in E. coli
showed that both were equally effective in terms of sensitivity and specificity.
Conclusions: Our results therefore indicate that either of these proteins can be used in serological tests in Brazil.
Background
The genus Hantavirus of the family Bunyaviridae
includes more than 30 viral species distributed through-
out the world. These rodent-borne viruses have been
increasing importance in global public health, being
transmitted to humans through contact with contami-
nated feces or intimate contact with infected rodents [1].
Hantaviruses have diameters ranging from 71 to 149
nm (average diameter: 112 nm). The virus particle is
enveloped by a lipid bilayer of approximately 7 nm thick
in which its surface glycoproteins (Gn and Gc) are
attached. The nucleocapsids are formed by a delicate
web of filamentous granular protein (N), which protects
and interacts with each of the 3 segments of viral RNA
(vRNA). The RNA molecules that form the virus gen-
ome are single stranded with negative polarity. They
have complementary sequences at the 3’ and 5’ end,
which allows the viral RNA remain circular within the
virion. The RNA segments are named according to their
size as L (large), M (medium) and S (small). The L seg-
ment has approximately 6500 nucleotides and encodes
the viral RNA-dependent RNA polymerase. This enzyme
is responsible for transcription and replication of the
viral genome and, as expected for RNA virus with nega-
tive polarity, is present in the virion. The M segment
(medium), with 3600 to 3800 nucleotides, encodes a
polyprotein precursor (GPC) which, after cleavage, leads
the two viral surface glycoproteins, Gn and Gc. The S
segment (small), with 1300 to 2100 nucleotides, encodes
the N protein [2]. This protein is abundantly produced
after infection and is responsible for several important
viral functions such as, preventing the degradation of
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of the infection process favoring viral assembly [3]. The
protein also induces strong humoral response, in both,
patients and rodents, with antibodies directed to the 3
major epitopes of N, which are located in the amino
terminal protein region [4].
The human infection by Hantavirus can cause 2 dis-
eases depending on the region of the globe where the
patient became infected: hemorrhagic fever with renal
syndrome (HFRS) in Asia and Europe and the Cardio-
pulmonary Syndrome (HCPS) in the Americas. While
the former is transmitted by Murinae and Arvicolinae
rodents of the Old World, the latter is transmitted by
Sigmodontinae rodents of the New World [1].
HCPS was reported for first time in the Americas, in
1993, causing pneumonia with respiratory failure among
Navajo Indians in the Four Corners region of USA. In
the same year, the first cases were reported in the Brazi-
lian city of Juquitiba and a couple thousand of HCPS
cases have been reported across America [5,6]. Accord-
ing to the Ministry of Health of Brazil, by the year 2009,
about 1200 HCPS cases were reported, with a 39% case
fatality rate [7]. At least 5 Hantavirus are the causatives
of HCPS in Brazil: Juquitiba virus (JUQV), Araraquara
virus (ARAV), Laguna Negra virus (LNV), Castelo dos
Sonhos virus (CASV) and Anajatuba virus (ANAJV).
Among these, ARAV has been the main causative of
HCPS, occurring in the “Cerrado” landscapes of South-
east and Central Plateau and producing about 49% of
fatalities [8]. In fact, ARAV has been considered the
most virulent Hantavirus in Brazil and probably in the
world [8].
The diagnosis of HCPS in Brazil is based on the clini-
cal presentation previous contact with rodents and
detection of IgM antibodies to Hantavírus [9]. In Brazil,
until a few years ago the ELISA for Hantavirus diagnosis
was performed only by public health laboratories, using
recombinant proteins of Sin Nombre virus (SNV) and
Andes virus (ANDV), from the Centers for Disease Con-
trol (USA) and Instituto Carlos Malbran (Argentina),
respectively, as antigens [1].
Recently, a recombinant N protein of ARAV was
produced [10]. The RNA used for the synthesis of the
vector was obtained from virus particle taken from
blood samples of an HCPS patient. The entire S seg-
ment of the virus was amplified and sequenced. The
analysis of the sequence revealed a segment of 1858
nucleotides with an open reading frame that encodes a
protein of 429 amino acids. The nucleotide sequence
confirmed a high identity with the N protein gene of
ARAV. The entire gene was cloned in the vector
pET200D and the N protein was expressed in Escheri-
chia coli BL21 strain [10]. The expression of the
recombinant protein was confirmed by the detection of
a 52-kDa protein by Western blot using a pool of
human sera obtained from HCPS patients [10]. This
recombinant protein was purified and has been used as
antigen in ELISA for detection of IgG and IgM antibo-
dies against Hantavirus [10]. However, studies compar-
ing serological methods for detection of Hantavirus,
indicate that recombinant proteins expressed in bacu-
lovirus expression system using insect cells, may be
more suitable, in terms of expression levels and also
easier for purification [11-13].
Here we report the expression of the N recombinant
protein of ARAV in insect cells using the baculovirus
expression system, the use of this protein as antigen in
ELISA was evaluated and compared to antigen produced
in Escherichia coli.
Methods
Cloning of Nucleoprotein gene in the baculovirus transfer
vector.
The N gene of Araraquara Hantavirus used in this study
was obtained from the plasmid pET-N-ARA [10]. This
gene was originally isolated by RT-PCR from the serum
of patients with HCPS and cloned into the expression
vector pET Directional TOPO
® (Invitrogen USA) [10].
The DNA from this plasmid was used as template for
Polimerase Chain Reaction (PCR) using the Forward
Histidine and Reverse Nucleoprotein primers (Table 1).
The amplicon containing the entire N gene was purified
using the GFX purification kit (Amersham, USA) and
cloned into the vector PCR2.1 (Invitrogen USA), follow-
ing manufacturer’s instructions. The plasmid obtained,
named PCR 2.1-Hist-N, was subsequently digested with
BglII (Biolabs USA) and XmaI (Biolabs USA) restriction
enzymes in order to release the fragment of interest.
After purification, this fragment was inserted into the
transfer vector pSynXIV VI
+X3 [14]. This transfer vector
contains two promoters (pSYN and pXIV) in tanden
driving the expresson of the foreign gene. The transfer
vector containing the insert and named pSyn-Hist-N
was sequenced in order to confirm the correct insertion.
The sequencing reaction was carried out using the Big-
Dye v.3 kit (Applied Biosystems USA) using specific pri-
mers (Table 1) and run in an ABI Prism 377 sequencer
(Applied Biosystems USA). The sequences obtained
were assembled using the CodonCode Aligner program
version 1.3.4 (CodonCode Corporation). Subsequently,
these sequences were analyzed using the ORF finder
and BLAST software (National Center for Biotechnology
Information - NCBI).
Construction of the recombinant baculovirus
Monolayers of SF-9 cells (1 × 10
6 cells or 50 to 70% cell
density) were co-transfected with a solution containing
0.5 μg of the DNA of baculovirus vSynVI-gal linearized
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Hist-N previously incubated with a 50 ul solution of
lipofectin (Gibco-BRL). After incubation, for 3 hours, at
27°C, the cell culture medium was exchanged for fresh
medium and the cell culture was further incubated at
27°C for 5 to 7 days. The vSynVI
-gal virus is a recombi-
nant baculovirus derived from the Autographa califor-
nica multiple nucleopolyhedrovirus (AcMNPV)
containing the b-galactosidase gene (lac-Z)f r o mE. coli
in place of the occlusion body protein gene (polh) [14].
These cells were then observed under an optical light
microscope, to visualize viral occlusion bodies (indica-
tive of recombination, since the pSyn-Hist-N vector has,
besides the N gene, the polh gene). The cell superna-
tants, containing recombinant viruses, were removed
and stored for further confirmation of gene insertion as
well as for titration and purification of the recombinant
viruses. To confirm the insertion of the gene of interest,
the DNA of the recombinant baculovirus was extracted
and a PCR with specific primers, Forward Histidine and
Reverse Nucleoprotein, (Table 1) was performed.
Purification and titration of recombinant baculovirus
Serial dilutions of supernatant of the infected cells (5 to
7 days after transfection) were performed and used to
infect Sf9 cells in 96 well plates. The identification of
recombinant viruses infecting these cells was done by
the presence of occlusion bodies in the nucleus. The
cells infected with the highest dilutions and having
occlusion bodies in the nucleus were selected and had
the supernatants used for other serial dilutions. This
process was done for 3 times in order to obtain purified
recombinant viruses. The purity of the recombinant
virus was checked by a PCR that amplifies the b-galac-
tosidase gene, using specific primers, forward b-gal and
reverse b-gal (Table 1). Knowing that this gene was
replaced by the gene of interest, the absence of b-galac-
tosidase indicates an adequate purity of the recombinant
virus. The supernatant of the infected cells with the
purified recombinant virus was collected, titrated by pla-
que assay, and stored at 4°C.
Production and analysis of recombinant proteins
Sf9 cells (2 × 10
6 c e l l s / m l )g r o w ni n7 5m m
2 culture
flasks were infected with 5 MOI of the recombinant
virus and incubated at 27°C. After 72 h p.i. the cells
were collected and analyzed for production of recombi-
nant proteins in both, native and denatured forms.
Thus, 2 samples of the infected cells were used. The
first sample was collected by low speed centrifugation in
a microcentrifuge, washed with PBS and lysed in a buf-
fer containing 50 mM NaH2PO4,3 0 0m MN a C l ,1 %
Tween 20, pH8.0 and protease inhibitors for 1 h at 4° C
under agitation. After this period, the cell lysate was
centrifuged at 10,000 × g for 10 minutes and the super-
natant was stored at -70°C. The second sample was sub-
mitted to the same procedure, but with lysis buffer
containing 6 M urea. Samples of both cell lysates con-
taining the recombinant protein were analyzed by polya-
crylamide gel electrophoresis (SDS-PAGE) and stained
with Coomassie blue.
Purification and antigenic analysis of recombinant
proteins
The denatured protein extract was passed through a col-
umn of nickel (Ni-NTA Purification System - Qiagen,
USA) which binds specifically to the histidine tail present
in the recombinant protein, allowing its purification. After
elution with a buffer containing: 50 mM NaH2PO4, 300
mM NaCl, 1% Tween 20, 6 M urea and protease inhibitors
pH 5.6 or pH 4.2, this eluate was checked for purity by
SDS-PAGE and stained with Coomassie blue. The crude
extract from infected SF9 cells with recombinant baculo-
virus and crude extract from uninfected SF9 cells were
subjected to a western blot using a Hantavirus immune
serum from a HCPS convalescing patient. Anti-Human
IgG linked to peroxidase (Sigma, USA) was used as sec-
ondary antibody and DAB (Sigma, USA) as substrate.
Table 1 Specific primers for amplification/sequencing of Araraquara hantavirus nucleoprotein gene and amplification
of betagalactosidase gene.
Primers
name
Primer
Sequence
Function
For. His. 5’ GAAGATCTATGCGGGGTTCTCATCAT 3’ Amplification of N gene.
Rev. NP. 5 TAACCCGGGTCACAGCTTTAAGGGTCC 3’ Amplification of N gene.
Int. NP. 5’ AGACAGCAGACTGGAAG 3’ Sequencing of N gene.
For. pSyn 5’ GGGCCAAGCTTGGCGTTATTG 3’ Sequencing of N gene
Rev. pSyn 5’ TCTGTAAATCAACAACGCACAG 3’ Sequencing of N gene
For. b-gal 5’ TTCACTGGCCGTCGTTTTACAACGTCGTGA 3’ Check of Recombinant Baculovírus Purity
Rev. b-gal 5’ ATGTGAGCGAGTAACAACCCGTCGGATTCT3’ Check of Recombinant Baculovírus Purity
Primers name: For. His - Forward Histidina; Rev. NP - Reverse Nucleoprotein; Int. NP. Intermediate Nucleoprotein; For. pSyn. Forward vector pSyn; Rev. pSyn.
Reverse vector pSyn; For. b-gal. Forward gene betagalactosidase; Rev. b-gal. Reverse gene betagalactosidase.
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Human sera obtained from 30 HCPS suspect patients,
collected from 2005 to 2009 at hospitals in the cities of
Ribeirão Preto, Sertãozinho e Jardinópolis were tested
by IgG ELISA using the N recombinant proteins of
ARAV as antigens. Additionally, 50 sera collected from
participants of a Hantavirus serologic survey in the cities
of Paraiso and Belmonte, state of Santa Catarina, were
also tested by ELISA.
Enzyme Linked Immunosorbent Assay- ELISA
An ELISA using recombinant protein produced in insect
cells was standardized using the protocol previously
established by Figueiredo and collaborators (2008) [10].
The microplates of 96 wells were divided in two parts.
The wells in the first part of the plate, including rows A
to D, columns 1 to 12, were coated with 2.0 μg/ml of the
N recombinant protein in carbonate-bicarbonate buffer
pH 9,6. The second part of the plate, rows E to H col-
umns 1 to 12, had the wells coated with the negative anti-
gen control (crude extract from uninfected Sf9 cells).
After an overnight incubation, at 4°C, the microplates
were washed 6 times with PBST buffer (Phosphate Buffer
plus 20% Tween). All tested sera (positive and negative
controls) were diluted 1:100 in PBS containing 10%
skimmed milk and added into duplicate wells in both
parts of the microplate (the part coated with N recombi-
nant protein and the part containing the negative anti-
gen). The microplates were washed as described above
and incubated at 37°C, for 1 h, with 50 μLo fa na n t i -
human IgG immunoglobulin - peroxidase conjugate
(Sigma USA), diluted 1:2000. The microplates were
washed again, as previously described, and 100 μlo f2 , 2
‘-azin-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS)
substrate (Sigma-Aldrich, USA) was added to the micro-
plate wells. The test was read in a spectrophotometer at
405 nm. The cut off of the test was considered as the
mean plus 3 standard deviations of the optical density
(OD) values obtained from all negative control samples,
after subtraction of the OD from all these negative sera
i nr o w sEt oH .T h eI g ME L I S Aw a sa l s os t a n d a r d i z e d
using the same protocol performed for IgG ELISA using,
as secondary antibody, anti-human IgM immunoglobulin
- peroxidase conjugate (Sigma USA), diluted 1:2000.
Comparison of ELISAs using recombinant N protein
produced in Baculovirus and E. coli expression systems
Thirty patients suspect of HCPS were tested by the IgG
ELISA previously described, coated with N recombinant
proteins of ARAV produced in Baculovirus (rN-Bac) or
E. coli (rN-E. coli) expression systems. OD values, as
well as cut-off values of tests using both antigens were
compared regarding to sensitivity and specificity. Posi-
tive samples by IgG ELISA were also tested by IgM
ELISA using both N recombinant proteins of ARAV as
antigens. Titles of samples and OD values, as well as
cut-off values of tests using both antigens were also
compared. The IgG ELISA was also used to test sera of
50 volunteers from Paraíso and Belmonte cities.
Results
N gene amplification and cloning
The RT-PCR amplification of the N gene of Araraquara
Hantavirus generated a fragment of approximately 1287
nt. This gene was subsequently cloned into a transfer
vector pSynXIVVI+X3 (5.8 Kb) producing a 7.1 Kb plas-
mid [14]. The nucleotide sequence of the insert (cassette
pSyn-Hist-N) showed 100% identity with the S segment
sequence of Araraquara virus deposited in the GenBank
(EF571895 and AF3073225). The ORF contained in the
insert had 1287 nt, encoding a putative protein of 429
amino acids which also shown to be identical to the N
protein of Araraquara virus.
Construction, purification and titration of the
recombinant baculovirus
Five days after the co-transfection that produced the
recombinant viruses, the Sf9 cells showed presence of
polyhedra (viral occlusion bodies) in the cells nuclei, sig-
naling the infection, of more than 80% of the cells. The
Hantavirus N gene was also found inserted in the gen-
ome of the new vSyn-Hist-N recombinant baculovirus
and it was successfully purified by serial dilution which
was confirmed by the lack of amplification of the b-
galactosidase gene in a PCR. The vSyn-Hist-N was
obtained at a titer of 1.3 x10
7 pfu/ml.
Production, purification and antigenic analysis of
recombinant protein
The expressed Hantavirus N protein was extracted with
a buffer solution containing urea. Thus, large amounts
of the 52 kDa N recombinant protein were obtained
after this denaturing extraction (Figure 1A). Native
extraction of N recombinant protein was also investi-
gated. However, only small amounts of recombinant N
protein were obtained by this method (data no shown).
The protein was purified using nickel column (Figure
1B). The crude extract from infected SF9 cells with
recombinant baculovirus and crude extract from unin-
fected SF9 cells was analyzed by western blot. Sera from
HCPS patients were able to react, in this test, with the
N recombinant protein (rN-Bac) present in the extract
of infected Sf9 cells, as shown in Figure 1C.
Comparison of ELISAs using rN-Bac and rN-E. coli as
antigen
Sera from 30 HCPS suspected patients were diluted
1:100 and tested by IgG-ELISAs, using rN-Bac or rN-E.
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(63%) were negative by both tests. As shown in Table 2
no significant difference (p > 0.05) in optical densities
and similar cut-off values were observed in both IgG
ELISAs (0.172 to rN-Bac and 0.193 to rN-E. coli). These
eleven positive sera were later tested by Hantavirus rN-
Bac and rN-E. coli IgM ELISA. Six sera (54,5%) were
positive, showing titles between 100 and 200. The other
5 sera (45,5%) were negative by both tests (Table 3). No
significant differences were observed (p > 0.05) on opti-
cal densities or serum titers. Similar cut-off values were
observed in both IgM ELISAs (0.189 to rN-Bac and
0.201 to rN-E. coli). Hantavirus rN-Bac and rN-E. coli
IgG-ELISAs were also used to test 50 samples of volun-
teers from the towns of Paraíso and Belmonte, State of
Santa Catarina, showing 12 positives (24%) and 38 (76%)
negatives in both tests. As we previously observed with
sera from the 30 HCPS suspected patients, no signifi-
cant difference (p > 0,05) in optical densities and similar
cutt-off values (0.274 for rN-Bac and 0.290 for rN-E.
coli) were observed for the 50 samples of volunteers, as
s h o w ni nT a b l e4 .B a s e do nt h i sc o m p a r i s o nw i t ht h e
Hantavirus IgG or IgM ELISA using rN-E. coli as anti-
gen, the antigen commonly used in Brazil, the rN-Bac
IgG or IgM -ELISA showed 100% sensitivity, specificity
and predictive values.
Discussion
The production of native antigens for Hantavirus serolo-
gical tests has several limitations, including a high risk
of contamination by handling the virus, low viral titers
obtained in cell culture, difficulty in adapting the virus
to cells, slow viral replication (3 to 10 days), and occur-
rence of virus mutations after successive passages in cell
culture [15]. Thus, Hantavirus antigens produced by
recombinant DNA technology became a common
approach for this purpose [16]. The N protein contains
important viral antigens and has been previously pro-
duced by recombinant techniques for use in serologic
diagnosis [17,18]. In the present study, we have success-
fully expressed the recombinant N protein of Arara-
quara Hantavirus in insect cells by recombinant
Figure 1 Expression, purification and antigenic analysis by
western-blot of recombinant Nucleoprotein, expressed in
Baculovírus expression system. A. Polyacrilamide gel
electrophoresis 12,5% stained with Coomassie blue showing the
expression of recombinant N protein. 1. BenchMark Protein Ladder
(Bio-rad-USA), 2. Crude extract from uninfected Sf9 cells, 3. Crude
extract from infected SF9 cells with recombinant Baculovirus. B.
Polyacrilamide gel electrophoresis 12,5% stained with Coomassie
blue showing the purification of recombinant N protein. 1.
BenchMark Protein Ladder (Bio-rad-USA), 2/3. Purified recombinant
N protein. C. Western-blot showing the recombinant N protein
detection by HCPS serum sample. 1. BenchMark Protein Ladder
(Fermentas-BRL), 2. Crude extract from infected SF9 cells with
recombinant baculovirus showing the detection of recombinant N
protein, 3. Crude extract from uninfected SF9 cells without
detection of recombinant N protein.
Table 2 Comparative IgG ELISA-rN-Bac and IgG ELISA-rN-
E. coli against sera suspected HCPS received in the
Virology Research Center - FMRP.
N° Patients Sex Age rN-Bac
OD
rN-E. coli
OD
Results
1
1 M 20 1.287 1.173 (+)/(+)
2 F 23 0.160 0.181 (-)/(-)
3 M 53 0.151 0.187 (-)/(-)
4 M I 0.989 1.090 (+)/(+)
5 M 49 0.159 0.156 (-)/(-)
6 F I 0.101 0.111 (-)/(-)
7 F I 0.092 0.097 (-)/(-)
8 M 39 0.105 0.143 (-)/(-)
9 M 25 1.430 1.560 (+)/(+)
10 M 39 0.107 0.131 (-)/(-)
11 M 30 0.110 0.107 (-)/(-)
12 F 34 0.954 1.102 (+)/(+)
13 M 44 0.095 0.078 (-)/(-)
14 M I 1.153 1.051 (+)/(+)
15 M 28 1.502 1.362 (+)/(+)
16 F 40 0.113 0.134 (-)/(-)
17 M 38 0.117 0.118 (-)/(-)
18 F 25 1.021 0.897 (+)/(+)
19 F 23 0.087 0.091 (-)/(-)
20 M 39 0.127 0.162 (-)/(-)
21 M 40 0.121 0.154 (-)/(-)
22 M I 1.923 1.597 (+)/(+)
23 M 38 0.118 0.168 (-)/(-)
24 M I 1.720 1.614 (+)/(+)
25 M I 0.133 0.147 (-)/(-)
26 F 15 1.133 1.315 (+)/(+)
27 F 22 0.108 0.133 (-)/(-)
28 M 52 0.159 0.178 (-)/(-)
29 M I 1.081 1.209 (+)/(+)
30 M 46 0.136 0.133 (-)/(-)
OD - Optical Density. ELISA - Enzyme Linked immunosorbent assay. Bac -
Baculovirus. E. coli - Escherichia coli. 1. Result of assay used IgG-ELISA-rN-Bac
and IgG-ELISA-rN-E. coli.
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under control of very late baculovirus promoter, high
levels of the rN-Bac were obtained after 72 h p.i. as
observed by other authors expressing their proteins in
insect cells using similar vectors [15,19-22]. However,
rN-Bac was mostly present in intra-cytoplasmatic inclu-
sion bodies and required denaturing buffer solutions for
a adequate purification. The recombinant protein was
analyzed by western blot showing suitable antigenic
characteristics by strongly reacting with human sera
from HCPS patients.
The rN-Bac was used as an antigen in an IgG and
IgM ELISA which was able to detect anti-nucleoprotein
antibodies in both human and rodent sera (Data not
s h o w n ) .T h i sH a n t a v i r u sr N - B a cI g G - E L I S Aw a sc o m -
pared to a similar test using N recombinant protein
antigen produced in E. coli.T h er N - E. coli is used in
Brazil as the regular antigen for ELISA diagnosis of
Hantavirus infections. Eighty human serum samples
Table 3 Comparative IgM ELISA-rN-Bac and IgM ELISA-rN-
E. coli against confirmed sera of HCPS received in the
Virology Research Center - FMRP.
rN-Bac rN - E. coli
N°
Patients
Genus OD Title
Sample
OD Title
Sample
Results
1
1 M 0.142 No reagent 0.158 No reagent (-)/(-)
2 F 0.324 1:100 0.295 1:100 (+)/(+)
3 M 0.127 No reagent 0.139 No reagent (-)/(-)
4 M 0.339 1:200 0.351 1:200 (+)/(+)
5 M 0.114 No reagent 0.097 No reagent (-)/(-)
6 F 0.358 1:200 0.327 1:100 (+)/(+)
7 F 0.304 1:100 0.316 1:100 (+)/(+)
8 M 0.168 No reagent 0.147 No reagent (-)/(-)
9 M 0.116 No reagent 0.131 No reagent (-)/(-)
10 M 0.401 1:200 0.382 1:200 (+)/(+)
12 M 0.251 1:100 0.283 1:100 (+)/(+)
OD - Optical Density. ELISA - Enzyme Linked immunosorbent assay. Bac -
Baculovirus. E. coli - Escherichia coli. 1. Result of assay used IgM-ELISA-rN-Bac
and IgM-ELISA-rN-E. coli.
Table 4 Evaluation of IgG ELISA-rN-Bac and IgG ELISA-rN-E. coli against sera from volunteers from the cities of Paraíso
and Belmonte, SC.
Patients/City and
State of origin
Sex Age rN-Bac
OD
rN-E. coli
OD
Results
1 Patients/City and State of origin Sex Age rN-Bac
OD
rN-E. coli
OD
Results
1
1-Par-SC M 20 0.109 0.139 (-)/(-) 26-Par-SC M 24 0.219 0.240 (-)/(-)
2-Par-SC F 31 0.167 0.141 (-)/(-) 27-Par-SC M 69 0.782 0.992 (+)/(+)
3-Bel-SC M 35 0.181 0.191 (-)/(-) 28-Par-SC M 31 0.137 0.118 (-)/(-)
4-Bel-SC F 50 1.058 0.912 (+)/(+) 29-Bel-SC F 59 0.156 0.194 (-)/(-)
5-Par-SC M 42 0.098 0.167 (-)/(-) 30-Bel-SC M 30 0.194 0.173 (-)/(-)
6-Par-SC M 86 1.218 1.054 (+)/(+) 31-Bel-SC M 27 0.149 0.181 (-)/(-)
7-Par-SC M 48 1.023 1.162 (+)/(+) 32-Par-SC F 46 0.107 0.081 (-)/(-)
8-Par-SC F 47 0.137 0.179 (-)/(-) 33-Bel-SC F 18 0.864 0.719 (+)/(+)
9-Bel-SC F 31 0.121 0.140 (-)/(-) 34-Par-SC M 57 0.186 0.202 (-)/(-)
10-Bel-SC F 37 0.129 0.104 (-)/(-) 35-Par-SC M 40 0.243 0.217 (-)/(-)
11-Bel-SC F 21 0.108 0.096 (-)/(-) 36-Par-SC M 31 0.154 0.091 (-)/(-)
12-Par-SC M 29 0.089 0.102 (-)/(-) 37-Par-SC F 19 0.147 0.137 (-)/(-)
13-Par-SC F 27 0.911 0.816 (+)/(+) 38-Par-SC F 56 1.534 1.209 (+)/(+)
14-Bel-SC M 45 0.097 0.089 (-)/(-) 39-Par-SC F 26 0.136 0.143 (-)/(-)
15-Bel-SC M 40 0.162 0.143 (-)/(-) 40-Bel-SC M 62 0.098 0.079 (-)/(-)
16-Par-SC F 39 0.141 0.156 (-)/(-) 41-Par-SC F 76 0.942 0.985 (+)/(+)
17-Bel-SC F 52 0.182 0.167 (-)/(-) 42-Par-SC F 74 0.137 0.199 (-)/(-)
18-Bel-SC M 56 1.102 0.977 (+)/(+) 43-Bel-SC F 51 0.139 0.142 (-)/(-)
19-Par-SC F 31 0.116 0.095 (-)/(-) 44-Bel-SC F 27 1.367 1.418 (+)/(+)
20-Par-SC F 60 0.087 0.073 (-)/(-) 45-Bel-SC M 43 0.142 0.125 (-)/(-)
21-Par-SC F 27 0.213 0.192 (-)/(-) 46-Bel-SC M 36 0.101 0.089 (-)/(-)
22-Par-SC M 39 0.183 0.207 (-)/(-) 47-Par-SC F 31 0.128 0.151 (-)/(-)
23-Par-SC F 57 1.006 1.355 (+)/(+) 48-Par-SC M 20 0.191 0.168 (-)/(-)
24-Bel-SC M 24 0.173 0.197 (-)/(-) 49-Par-SC M 48 0.639 0.567 (+)/(+)
25-Par-SC M 37 0.094 0.056 (-)/(-) 50-Bel-SC F 38 0.208 0.231 (-)/(-)
Par- Paraíso. Bel- Belmonte. SC - Santa Catarina. OD - Optical Density. ELISA - Enzyme Linked immunosorbent assay. Bac - Baculovirus. E. coli - Escherichia coli.1 .
Results of IgG-ELISA-rN-Bac and IgG-ELISA-rN-E. coli.
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Page 6 of 8were tested by both ELISAs showing equal results, 23
samples were positive and 67 were negative. No signifi-
cant differences were observed for optical density values
and test cut-off values in both tests. Hantavirus rN-Bac
and rN-E. coli IgM ELISAs showed both to be usefull as
diagnostic tools. Among eleven tested sera, 6 were posi-
tives and 5 negatives in both tests. Thus, no significant
differences were observed on optical densities, serum
titers and the cut-offs of both tests showed close values.
These results showed that the IgG or IgM ELISA using
rN-Bac as antigen were equally effective to the rN-E.
coli IgG or IgM ELISA in terms of sensitivity and
specificity.
Previous comparison of serological methods for the
diagnosis of Hantavirus infection indicated that ELISA
assays with N protein produced in E. coli was less sensi-
tive than assays performed with N protein produced in
insect cells through the Baculovirus system [11]. The
same study also showed that even after several rounds
of purification the presence of residues from E. coli
could still generate false positive results [11].
Conclusion
An N recombinant protein of Araraquara Hantavirus
was successfully produced in insect cells and the preli-
minary tests of this protein as an ELISA antigen encou-
rage its use for diagnosis of HCPS and
seroepidemiological surveys of Hantavirus in Brazil.
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